RRE Ventures director-linked LLC granted warrants, B shares
RRE Ventures Acquisition Corp. director awards via affiliated LLC show compensation-style grants rather than open-market trades.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RRE Ventures Acquisition Corp. director awards via affiliated LLC show compensation-style grants rather than open-market trades. Keegan Investment Holdings, LLC, an entity associated with director Brian Frederick Daly, received 250,000 private placement warrants at $1.00 each, exercisable for Class A Ordinary Shares at $11.50 per share after the company’s initial business combination. The same LLC also received 75,000 and then an additional 30,000 Class B Ordinary Shares, which are convertible into Class A Ordinary Shares on a one-for-one basis with no expiration.
Insights
Filing shows routine equity awards to an entity linked to a director.
The transactions reflect grant/award acquisitions of warrants and Class B Ordinary Shares by Keegan Investment Holdings, LLC, which is associated with director Brian Frederick Daly. These are compensation-style awards, not open-market purchases or sales, so they carry weaker signaling value about near-term stock views.
The LLC now holds 250,000 private placement warrants at an $11.50 exercise price and a total of 105,000 Class B Ordinary Shares. The Class B shares automatically convert into Class A shares at the time of the issuer’s initial business combination, or earlier at the reporting person’s option, which ties ultimate value to that future transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Warrant | 250,000 | $1.00 | $250K |
| Grant/Award | Class B Ordinary Shares | 30,000 | $0.00 | $0.00 |
| Grant/Award | Class B Ordinary Shares | 75,000 | $0.00 | $0.00 |
Footnotes (3)
- F1. The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date.
- F2. These securities were previously reported on a Form 3 filed by the Reporting Person.
- F3. The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.
Key Figures
Key Terms
private placement warrants financial
initial business combination financial
Form 3 regulatory
liquidation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RRE Ventures Acquisition Corp. director Brian Frederick Daly report in this Form 4 for RREVU?
How many private placement warrants were granted in the RREVU Form 4 filing?
Are the transactions in this RRE Ventures Acquisition Corp. Form 4 open-market buys or sales?
When do the private placement warrants reported for RREVU become exercisable and when do they expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.